QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. (QNRX) is expected to report earnings on February 4, 2027, before the market open. The consensus earnings estimate is a loss of $1.90 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -10.4% since its last earnings release on November 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare and orphan diseases. Quoin Pharmaceuticals, formerly known as Cellect Biotechnology Ltd., is based in Tel Aviv.
Sector
Healthcare
Industry
Drug Manufacturers/Other
Charts powered in part by Lightweight Charts™ by TradingView.